Watch Live

Tweet TWEET

Clavis Pharma ASA: Information from the Election Committee

          Clavis Pharma ASA: Information from the Election Committee

Oslo, Norway, 4 October 2013

Clavis Pharma ASA (OSE: CLAVIS), reference is made to the announcement on 17
September 2013 regarding Clavis Pharma's Extraordinary General Meeting to be
held on 8 October, and agenda item 7: Election of Board. Please find attached
additional information from the Election Committee in regards to this agenda
item.

                                    *****

Contact:
Gunnar Manum
Acting CEO and CFO
+47 95 17 91 90 (mob)
gunnar.manum@clavispharma.com


This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Clavis Pharma recommendation by the Election Committee

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Clavis Pharma ASA via Thomson Reuters ONE
HUG#1733728